This event has been canceled for October 24, 2019. Please check back for 2020 Saving Sight Session dates. You can stay up-to-date with the latest department news by signing up for our newsletter at the bottom of this page.

[canceled] Advancements in Pediatric Ophthalmology

About Dr. Bradfield

Dr. Bradfield is a pediatric ophthalmology and adult strabismus specialist. She is internationally recognized as a leading expert in pediatric glaucoma. Dr. Bradfield’s academic work is focused on pediatric ophthalmology clinical trials, particularly through the Pediatric Eye Disease and Investigator Group and participation at the leadership level within the American Association for Pediatric Ophthalmology and Strabismus. Dr. Bradfield is the co-Chair of the International Ophthalmology Initiatives Committee and has worked tirelessly to develop international residency rotations in Brazil and the Philippines. Dr. Bradfield received the 2017 teaching award for resident education, and she remains dedicated to teaching medical students, residents and fellows.




Reading glasses with eye chart isolated on white.

Continuing education for optometrists presented by the University of Wisconsin Department of Ophthalmology and Visual Sciences and UW Health Eye Clinics. Presentations will be held at the Health Sciences Learning Center adjacent to University Hospital in Madison. Complimentary dinner/reception will follow.


2019 Program

8:15 – 8:45am Breakfast/Registration
8:45 – 9:00 Introduction and Welcome Eugene Cropp, OD
9:00 – 9:30 Retinal Vein Occlusions Justin Gottlieb, MD
9:30 – 9:50 Review of the Secondary Glaucomas Daniel Knoch, MD
9:50 – 10:10 Visual Fields Associated With Neuro Disease Yanjun (Judy) Chen, MD, PhD
10:10 – 10:40 Evaluation and Management of Iritis Laura Kopplin, MD, PhD
10:40 – 11:00 Break
11:00 – 11:20 Inherited Retinal Degenerations Update Kimberly Stepien, MD
11:20 – 11:40 Evaluation and Management of Hyphemas Jennifer Larson, MD
11:40 – 12:00 Management of Thyroid Disease Suzanne van Landingham, MD
12:00 – 12:20 The Many Faces of Melanomas Heather Potter, MD
12:20 – 1:20 Lunch
1:20 – 1:50 Concussion Management Kellye Knueppel, OD
1:50 – 2:10 Evaluation of Corneal Astigmatism for Cataract Surgery Patricia Sabb, MD
2:10 – 2:30 Neurotrophic Corneal Disease Evan Warner, MD
2:30 – 2:50 Break
2:50 – 3:10 Corneal Neurotization Cat Burkat, MD, FACS
3:10 – 3:40 Assessment and Management of Vitreoretinal Interface Disorders Michael Altaweel, MD
3:40 – 4:10 Complications From “Minimally Invasive” Glaucoma Surgery Yao Liu, MD, MS
4:10 – 4:20 Program Conclusion Eugene Cropp, OD
4:30 Reception and Dinner Buffet Buck & Honey’s Monona


This program has been submitted to the Wisconsin Optometric Examining Board for six hours of continuing education credit for optometrists (includes one hour of glaucoma approved education). The views expressed in these presentations are those of the speaker and authors, and do not reflect the official policies of the University of Wisconsin – Madison School of Medicine and Public Health Department of Ophthalmology and Visual Sciences.



Presented by the UW Department of Ophthalmology and Visual Sciences


Monice Vetter, PhDKeynote Speaker: MOnica Vetter, PhD – UNiversity of Utah – Chair of the Department of neurobiology and Anatomy

Dr. Vetter’s laboratory is focused on understanding the molecular pathways controlling neural development and degeneration in the retina. The retina is of critical importance since disorders of eye development can lead to congenital blindness, while degeneration of retinal neurons can cause progressive blindness at later ages.

Featured Speakers:

  • Michael G. Anderson, PhD, Professor of Molecular Physiology and Biophysics; Ophthalmology and Visual Sciences within the Carver College of Medicine at the University of Iowa
  • Amy Lee, PhD, Professor of Molecular Physiology and Biophysics, Otolaryngology Head-Neck Surgery, and Neurology Assistant Dean for Research within the Carver College of Medicine at the University of Iowa
  • Katie M. Litts, PhD, Postdoctoral Fellow within the Advanced Ocular Imaging Program at the Medical College of Wisconsin Eye Institute




8:00 – 8:20 AM   Breakfast and Registration 

8:20 – 8:30 AM   Chair’s Welcome: Terri Young, MD, MBA

Session I   Retina and the Visual Pathway // Moderator: Justin Gottlieb, MD

  • 8:30 – 8:50 AM Amy Lee, PhD // Cav1.4 Ca2+ Channels at the Photoreceptor Synapse
  • 8:50 – 9:10 AM Raunak Sinha, PhD // Diversity of Photoreceptor Signaling in Primate Retina
  • 9:10 – 9:30 AM Karen Schloss, PhD // The Role of Visual Reasoning in Visual Communication 
  • 9:30 – 9:50 AM Mrinalini Hoon, PhD // Development of Retinal Presynaptic Inhibitory Circuits 
  • 9:50 – 10.10 AM Krista Christensen, MPH, PhD // Macular Pigment and Low Luminance Vision in CAREDS

10:10 – 10:25 AM   Break

Session II  Glaucoma // Moderator: Gregg Heatley, MD, MMM

  • 10:25 – 10:45 AM  Michael Anderson, PhD // Using Quantitative Image Analysis to Empower Mouse studies of Glaucoma and Retinal Ganglion Cell Biology
  • 10:45 – 11:05 AM  Donna Peters, PhD // αVb3 Integrin Signaling Controls Intraocular Pressure
  • 11:05 – 11:25 AM  Colleen McDowell, PhD // TLR4 Signaling in The Human Trabecular Meshwork
  • 11:25 – 11:45 AM Gillian McLellan, BVMS, PhD, DACVO // Glaucomatous Optic Nerve Neuro-Inflammation and Degeneration
  • 11:45 – 12:00 PM Sri Meghana Konda, MBBS // Schlemm’s Canal Imaging, Pressure and Catheterization

12:00 PM – 1:00 PM   Buffet Lunch 

Session III  Ocular Pathologies // Moderator: Evan Warner, MD

  • 1:00 – 1:20 PM Katie Litts, PhD // Application of AOSLO Retinal Imaging in Achromatopsia 
  • 1:20 – 1:35 PM Kara Vogel, PhD // Vigabatrin: Synaptic Remodeling of Retinal Bipolar Cells
  • 1:35 – 1:50 PM Barbara Blodi, MD // Ellipsoid Zone Status and Its Association with Visual Acuity in Eyes with Macular Edema in SCORE 2
  • 1:50 – 2:10 PM Donna Neumann, PhD // The Link Between Ocular HSV-1 Recurrence and Chromatin Loops
  • 2:10 – 2:30 PM  Curtis Brandt, PhD // In Vitro Susceptibility of FHV-1 Field Strains to Ganciclovir

2:30 – 2:50 PM Break

2:50 – 3:50 PM   Keynote Speaker: Monica Vetter, PhD // Microglia: Dynamic Remodelers of the Developing Retina

3:50 – 4:00 PM   Closing Remarks: Terri Young, MD, MBA


This slideshow requires JavaScript.


The 2019 Vision Research Symposium is supported by the Department of Ophthalmology and Visual Sciences

George Kambara Education Fund and McPherson Eye Research Institute.

Continuing education for optometrists presented by the University of Wisconsin Department of Ophthalmology and Visual Sciences and UW Health Eye Clinics. Presentations will be held at the Health Sciences Learning Center adjacent to University Hospital in Madison. Complimentary dinner/reception will follow.



2018 Program Schedule


8:45 – 9:00 Introduction and Welcome, Eugene Cropp, OD

9:00 – 9:30 Treatment of Proliferative Diabetic Retinopathy, Justin Gottlieb, MD 

9:30 – 9:50 Evaluation and Management of Dermatochalasis and Brow Ptosis, Mark Lucarelli, MD, FACS

9:50 – 10:10 Herpetic Keratitis, Daniel Knoch, MD

10:10 – 10:40 Idiopathic Intracranial Hypertension, Yanjun (Judy) Chen, MD, PhD

10:40 – 11:00 BREAK

11:00 – 11:20 Low Vision Resources and Magnifiers in Optometric Practice, Sanbrita Mondal, OD

11:20 – 11:40 Corneal Fungal Infections, Jennifer Larson, MD

11:40 – 12:10 Retinal Complications of Systemic Disease, Jonathan Chang, MD

12:10 – 12:30 Contraindications of Premium IOLs, Patricia Sabb, MD

12:30 – 1:30 LUNCH

1:30 – 1:50 When Traditional Sclerals Don’t Work, What Now?, Amy Walker, OD, MBA, FAAO

1:50 – 2:20 Trabecular Meshwork Bypass Surgery, Anna Momont, MD

2:20 – 2:40 Inherited Retinal Degenerations Update, Kimberly Stepien, MD

2:40 -2:50 BREAK

2:50 – 3:20 Update on DMEK, Evan Warner, MD

3:20 – 3:40 Latanoprostene and Netarsudil: Pharmacology and Niches, Gregg Heatley, MD, MMM





You are invited to a special Research Colloquium for a glaucoma research faculty candidate in the UW-Madison Department of Ophthalmology and Visual Sciences.

When: Thursday, August 30 from 3:30pm – 4:30pm

Where: Health Sciences Learning Center, 750 Highland Avenue, Room 1309

Who: Colleen McDowell, PhD, Assistant Professor at the North Texas Eye Research Institute at the University of North Texas Health Science Center

Presentation Title: “Cross-talk of TGFβ2 and TLR4 Pathways in the Trabecular Meshwork”

Dr. McDowell is currently an assistant professor at the North Texas Eye Research Institute at the University of North Texas Health Science Center in Fort Worth, TX. Her research is focused on studying a novel molecular pathway, TGFβ2 – TLR4 signaling crosstalk, in the development of elevated intraocular pressure and glaucomatous trabecular meshwork damage. In addition, Dr. McDowell studies retina ganglion cell subtype specific cell death in mouse models of glaucoma using mice that express GFP in specific individual subtypes of retina ganglion cells.

Dan Stamer Duke Eye Center“Restoring conventional outflow function: the next generation of glaucoma therapeutics”

Presented by W. Daniel Stamer, PhD from Duke University, Department of Ophthalmology and Albert Eye Research Institute

Program Agenda

3:00pm – Refreshments

3:30pm – Presentation

About Dr. Stamer’s Research

My laboratory studies the disease of glaucoma, the second leading cause of blindness in the United States, affecting nearly 3 million people (70 million Worldwide). The primary risk factor for developing glaucoma is ocular hypertension (high intraocular pressure, IOP). IOP is a function of aqueous humor moving into and out of the eye.  Elevated IOP in glaucoma is a result of disease in the primary efflux route, the conventional outflow pathway, affecting proper drainage of aqueous humor.

Controlling IOP in glaucoma patients, whether or not they have ocular hypertension, is important because large clinical trials involving tens of thousands of patients repeatedly demonstrate that significant, sustained IOP reduction slows or halts vision loss. Unfortunately, current daily medical treatments do not target the diseased conventional pathway and do not lower IOP sufficiently in most people with glaucoma. Therefore, finding new, more effective ways to medically control IOP by targeting the conventional pathway is a central goal the Stamer Laboratory.

Using molecular, cellular and organ-based model systems, my laboratory seeks to identify and validate novel drug targets in the human conventional outflow pathway such that novel treatment of ocular hypertension and glaucoma can be developed.